Solid Biosciences

SLDBNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$825.992 M

$8.39 -3.67%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

107,225,238

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#53Attovia TherapeuticsATTO$919.3M
#54Aura BiosciencesAURA$826.5M
#55Solid BiosciencesSLDB$826.0M
#56DBV TechnologiesDBVT$798.2M
#57Candel TherapeuticsCADL$775.9M

Where these numbers come from

Share counts and financials for Solid Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.